|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
US
|
NASDAQ
|
|
CNTA
|
Centessa Pharmaceuticals plc
|
US
|
NASDAQ
|
|
CPIX
|
Cumberland Pharmaceuticals Inc.
|
US
|
NASDAQ
|
|
CRDF
|
Cardiff Oncology, Inc.
|
US
|
NASDAQ
|
|
CRIS
|
Curis, Inc.
|
US
|
NASDAQ
|
|
CTXR
|
Citius Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CYBN
|
Cybin Inc.
|
US
|
AMEX
|
|
DARE
|
Dare Bioscience, Inc.
|
US
|
NASDAQ
|
|
DCPH
|
Deciphera Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
DRUG
|
Bright Minds Biosciences Inc.
|
US
|
NASDAQ
|
|
EBS
|
Emergent Biosolutions, Inc.
|
US
|
NYSE
|
|
EVO
|
Evotec SE
|
US
|
NASDAQ
|
|
FGH
|
FG Group Holdings Inc.
|
US
|
AMEX
|
|
GMAB
|
Genmab A/S
|
US
|
NASDAQ
|
|
GSK
|
GlaxoSmithKline PLC
|
US
|
NYSE
|
|
GTHX
|
G1 Therapeutics, Inc.
|
US
|
NASDAQ
|
|
HEXO
|
HEXO Corp.
|
US
|
NASDAQ
|
|
ICUI
|
ICU Medical, Inc.
|
US
|
NASDAQ
|
|
IMGN
|
ImmunoGen, Inc.
|
US
|
NASDAQ
|
|
IMPL
|
Impel NeuroPharma, Inc.
|
US
|
NASDAQ
|